Document ID: chunk:federal_register_of_legislation:F2022C00582:reg:9:p3
Version: federal_register_of_legislation:F2022C00582
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 10994–12529

of lymphoproliferative disorders is defined in the Schedule 1 - Dictionary.
(21)      having an autoimmune or inflammatory disorder from the specified list of autoimmune and inflammatory disorders, at the time of the clinical worsening of immune thrombocytopaenia;
Note: specified list of autoimmune and inflammatory disorders is defined in the Schedule 1 - Dictionary.
(22)      consuming a food or beverage from the specified list of food and beverages, within the six weeks before the clinical worsening of immune thrombocytopaenia;
Note: specified list of food and beverages is defined in the Schedule 1 - Dictionary.
(23)      consuming a food or beverage which is associated in the individual with the following:
(a)          the worsening of immune thrombocytopaenia within six weeks of consuming the food or beverage; and
(b)          recovery to the individual's baseline platelet level on ceasing consumption of the food or beverage; and
(c)          exclusion of other aetiologies for thrombocytopaenia; and
(d)          recurrence of the worsening of immune thrombocytopaenia on re-exposure to the food or beverage; or
(e)          identification of platelet reactive antibodies specific to the food or beverage;
(24)      having a solid organ or stem cell transplant before the clinical worsening of immune thrombocytopaenia;
(25)      having a solid organ cancer at the time of the clinical worsening of immune thrombocytopaenia;
(26)      inability to obtain appropriate clinical management for immune thrombocytopaenia.